Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,247
Total Claims
$1.2M
Drug Cost
506
Beneficiaries
$2,387
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+2%
Opioid rate vs peers
2.6% vs 2.6% avg
+124%
Cost per patient vs peers
$2,387 vs $1,068 avg
+85%
Brand preference vs peers
16.7% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.6%
Opioid Rate
374
Opioid Claims
$22K
Opioid Cost
35.8%
Long-Acting Rate
Brand vs Generic
Brand: 2,364 claims · $874K
Generic: 11,819 claims · $331K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 505 | $152K |
| Pimavanserin Tartrate | 22 | $51K |
| Semaglutide | 45 | $45K |
| Rivaroxaban | 119 | $40K |
| Empagliflozin | 79 | $28K |
| Epoetin Alfa | 30 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 92 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 57 | $18K |
| Linaclotide | 28 | $18K |
| Finerenone | 28 | $17K |
| Eslicarbazepine Acetate | 14 | $15K |
| Insulin Detemir | 46 | $15K |
| Linagliptin | 38 | $15K |
| Efavirenz/Emtricit/Tenofovr Df | 11 | $15K |
| Fluticasone/Vilanterol | 35 | $15K |
Prescribing Profile
Patient Profile
73
Avg Age
58%
Female
2.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About